428 related articles for article (PubMed ID: 8929914)
1. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
2. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
[TBL] [Abstract][Full Text] [Related]
3. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
4. trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus.
Goldsmith KT; Dion LD; Curiel DT; Garver RI
Virology; 1998 Sep; 248(2):406-19. PubMed ID: 9721248
[TBL] [Abstract][Full Text] [Related]
5. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes.
Steinwaerder DS; Carlson CA; Lieber A
Mol Ther; 2001 Sep; 4(3):211-6. PubMed ID: 11545611
[TBL] [Abstract][Full Text] [Related]
8. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
9. Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy.
Ghosh S; Duigou GJ
Cancer Res; 2005 Oct; 65(19):8936-43. PubMed ID: 16204066
[TBL] [Abstract][Full Text] [Related]
10. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
12. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes.
Scaria A; Curiel DT; Kay MA
Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990
[TBL] [Abstract][Full Text] [Related]
13. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
14. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.
Wang Q; Jia XC; Finer MH
Gene Ther; 1995 Dec; 2(10):775-83. PubMed ID: 8750018
[TBL] [Abstract][Full Text] [Related]
15. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
16. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
17. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins.
Grand RJ; Owen D; Rookes SM; Gallimore PH
Virology; 1996 Apr; 218(1):23-34. PubMed ID: 8615026
[TBL] [Abstract][Full Text] [Related]
18. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
[TBL] [Abstract][Full Text] [Related]
19. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.
Lockett LJ; Both GW
Virology; 2002 Mar; 294(2):333-41. PubMed ID: 12009875
[TBL] [Abstract][Full Text] [Related]
20. E1A RNA transcripts amplify adenovirus-mediated tumor reduction.
Dion LD; Goldsmith KT; Strong TV; Bilbao G; Curiel DT; Garver RI
Gene Ther; 1996 Nov; 3(11):1021-5. PubMed ID: 9044743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]